Pfizer: Booster shots were 95.6% effective in Phase 3 trials
Pfizer noted that a portion of the trial took place while the spread of the more contagious delta variant was prevalent.
United States Albert Bourlam Centers For Disease Drug Administration Disease Control Booster Shots Pfizer
Source: newschannel5.com